Telix Pharmaceuticals Limited Stock
Stocks
TLX
AU000000TLX2
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.68 AUD | -0.32% |
|
+9.50% | +40.00% |
| 06-23 | ASX Biggest Gainers | MT |
| 06-02 | Telix Pharmaceuticals, United Imaging Healthcare Sign MOU for US Theranostics Collaboration; Shares Down 3% | MT |
| Market Cap | 5.34B 3.68B 3.24B 2.99B 2.8B 5.24B 347B 35.94B 13.92B 171B 13.83B 13.53B 596B | P/E 2026 * |
996x | P/E 2027 * | 111x |
|---|---|---|---|---|---|
| Enterprise Value | 5.74B 3.96B 3.49B 3.22B 3.01B 5.64B 373B 38.67B 14.98B 184B 14.88B 14.55B 641B | EV / Sales 2026 * |
4.23x | EV / Sales 2027 * | 3.64x |
| Free-Float |
83.23% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Telix Pharmaceuticals Limited
| 1 day | -0.32% | ||
| 1 week | +9.50% | ||
| Current month | +20.34% | ||
| 1 month | +16.75% | ||
| 3 months | +23.17% | ||
| 6 months | +33.22% | ||
| Current year | +40.00% |
| 1 week | 14.07 |  | 16.06 |
| 1 month | 12.17 | | 16.06 |
| Current year | 8.26 | | 16.06 |
| 1 year | 8.26 | | 25.87 |
| 3 years | 8.2 | | 31.97 |
| 5 years | 3.55 | | 31.97 |
| 10 years | 0.46 | | 31.97 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 51 | 2017-01-02 | |
Darren Smith
DFI | Director of Finance/CFO | 60 | 2022-07-30 |
| Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 51 | 2017-01-02 | |
Mark Nelson
CHM | Chairman | 66 | 2026-02-02 |
Jann Skinner
BRD | Director/Board Member | 68 | 2018-06-18 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-10 | Buy | Director | 10,200 | 0.0030% | ||
| 05-25 | Free | Director | 21,597 | 0.0064% | ||
| 05-25 | Free | Founder | 27,121 | 0.0080% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.32% | +9.50% | -35.50% | +35.64% | 3.68B | |
| +0.93% | +8.30% | -5.90% | +2.03% | 45.45B | |
| +0.15% | +7.61% | +324.11% | +565.24% | 36.09B | |
| +0.36% | +5.50% | +3.87% | +54.57% | 30.81B | |
| +8.37% | +8.76% | +17.05% | -13.29% | 30.98B | |
| +7.60% | -1.09% | +12.49% | +20.82% | 24.62B | |
| -0.24% | +2.97% | - | - | 14.78B | |
| +8.30% | +12.19% | +62.65% | +129.55% | 14.65B | |
| +0.54% | +7.16% | +12.26% | +20.02% | 13.3B | |
| +0.70% | +2.97% | +93.04% | +93.04% | 12.65B | |
| Average | +2.64% | +6.49% | +53.78% | +100.85% | 22.7B | |
| Weighted average by Cap. | +2.81% | +6.27% | +68.38% | +121.32% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.36B 936M 824M 760M 711M 1.33B 88.23B 9.13B 3.54B 43.52B 3.51B 3.44B 151B | 1.59B 1.1B 965M 890M 833M 1.56B 103B 10.7B 4.14B 50.98B 4.12B 4.03B 177B |
| Net income | 6.1M 4.21M 3.7M 3.42M 3.19M 5.98M 396M 41.04M 15.9M 196M 15.79M 15.45M 680M | 43.61M 30.08M 26.48M 24.43M 22.85M 42.81M 2.84B 294M 114M 1.4B 113M 110M 4.87B |
| Net Debt | 405M 280M 246M 227M 212M 398M 26.36B 2.73B 1.06B 13B 1.05B 1.03B 45.23B | 443M 306M 269M 248M 232M 435M 28.83B 2.99B 1.16B 14.22B 1.15B 1.12B 49.48B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-25 | A$15.68 | -0.32% | 1,745,963 |
| 26-06-24 | A$15.73 | +8.04% | 3,701,343 |
| 26-06-23 | A$14.56 | +2.46% | 1,878,642 |
| 26-06-22 | A$14.21 | -2.00% | 1,273,119 |
| 26-06-19 | A$14.50 | +1.26% | 3,759,644 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TLX Stock
Select your edition
All financial news and data tailored to specific country editions
